Company registration number:
06612184
Cubic Pharmaceuticals Limited
Unaudited filleted financial statements
30 November 2024
Cubic Pharmaceuticals Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
Cubic Pharmaceuticals Limited
Directors and other information
|
|
|
|
Directors |
Mr Anwar Ali |
|
|
Mr Saumil Kiritkumar Bhatt |
|
|
|
|
|
|
|
Secretary |
Mr Arun Jangra |
|
|
|
|
|
|
|
Company number |
06612184 |
|
|
|
|
|
|
|
Registered office |
Unit 3 Sextant Park |
|
|
Neptune Close |
|
|
Medway City Estate |
|
|
Rochester, Kent |
|
|
ME2 4LU |
|
|
|
|
|
|
|
Accountants |
Doshi & Co. Accountants |
|
|
6th Floor |
|
|
AMP House |
|
|
Dingwall Road |
|
|
Croydon |
|
|
CR0 2LX |
|
|
|
Cubic Pharmaceuticals Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Cubic Pharmaceuticals Limited
Year ended 30 November 2024
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 30 November 2024 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Doshi & Co. Accountants
6th Floor
AMP House
Dingwall Road
Croydon
CR0 2LX
9 September 2025
Cubic Pharmaceuticals Limited
Statement of financial position
30 November 2024
|
|
|
2024 |
|
|
2023 |
|
|
|
|
£ |
£ |
|
£ |
£ |
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
2,141,606 |
|
|
2,143,177 |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
|
|
|
|
Current assets |
|
|
195,842 |
|
|
219,409 |
|
|
Prepayments and accrued income |
|
|
843 |
|
|
8,618 |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
196,685 |
|
|
228,027 |
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
|
(
589,908) |
|
|
(
577,197) |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
|
|
|
|
Net current liabilities |
|
|
|
(
393,223) |
|
|
(
349,170) |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
|
1,748,383 |
|
|
1,794,007 |
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due after more than one year |
|
|
|
(
121,572) |
|
|
(
265,296) |
|
|
|
|
|
|
|
|
|
Accruals and deferred income |
|
|
|
(
7,167) |
|
|
(
7,167) |
|
|
|
|
|
|
|
|
|
|
|
|
______ |
|
|
______ |
|
Net assets |
|
|
|
1,619,644 |
|
|
1,521,544 |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
1,619,644 |
|
|
1,521,544 |
|
|
|
|
______ |
|
|
______ |
|
|
|
|
|
|
|
|
Notes to the financial statements
Cubic Pharmaceuticals Limited
Year ended 30 November 2024
1.
Employee numbers
The average number of persons employed by the company during the year amounted to
4
(2023:
7
).
2.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Directors |
(
282,054) |
(
44,519) |
(
326,573) |
|
|
|
|
|
______ |
______ |
______ |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Directors |
(
88,756) |
(
193,298) |
(
282,054) |
|
|
|
|
|
______ |
______ |
______ |
|
|
|
|
|
|
|
|
|
|
|
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
09 September 2025
, and are signed on behalf of the board by:
Mr Saumil Kiritkumar Bhatt
Director
Company registration number:
06612184
The company is a private company limited by shares, registered in England and Wales.